Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Kärre K[au]:

Classification of current anticancer immunotherapies. Galluzzi L et al. Oncotarget. (2014)

Expression of CD226 is associated to but not required for NK cell education. Wagner AK et al. Nat Commun. (2017)

George Klein (1925-2016). Ernberg I et al. Nature. (2017)

Search results

Items: 1 to 50 of 201

1.

NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy.

Sottile R, Tannazi M, Johansson MH, Cristiani CM, Calabró L, Ventura V, Cutaia O, Chiarucci C, Covre A, Garofalo C, Pontén V, Tallerico R, Frumento P, Micke P, Maio M, Kärre K, Carbone E.

Int J Cancer. 2019 Oct 15;145(8):2238-2248. doi: 10.1002/ijc.32363. Epub 2019 May 13.

PMID:
31018250
2.

Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway.

Cristiani CM, Turdo A, Ventura V, Apuzzo T, Capone M, Madonna G, Mallardo D, Garofalo C, Giovannone ED, Grimaldi AM, Tallerico R, Marcenaro E, Pesce S, Del Zotto G, Agosti V, Costanzo FS, Gulletta E, Rizzo A, Moretta A, Karre K, Ascierto PA, Todaro M, Carbone E.

Cancer Immunol Res. 2019 May;7(5):841-852. doi: 10.1158/2326-6066.CIR-18-0651. Epub 2019 Apr 2.

PMID:
30940644
3.

Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition.

Sottile R, Federico G, Garofalo C, Tallerico R, Faniello MC, Quaresima B, Cristiani CM, Di Sanzo M, Cuda G, Ventura V, Wagner AK, Contrò G, Perrotti N, Gulletta E, Ferrone S, Kärre K, Costanzo FS, Carlomagno F, Carbone E.

Front Immunol. 2019 Feb 26;10:224. doi: 10.3389/fimmu.2019.00224. eCollection 2019.

4.

Expression of CD226 is associated to but not required for NK cell education.

Wagner AK, Kadri N, Snäll J, Brodin P, Gilfillan S, Colonna M, Bernhardt G, Höglund P, Kärre K, Chambers BJ.

Nat Commun. 2017 May 31;8:15627. doi: 10.1038/ncomms15627.

5.

NK cells control breast cancer and related cancer stem cell hematological spread.

Tallerico R, Conti L, Lanzardo S, Sottile R, Garofalo C, Wagner AK, Johansson MH, Cristiani CM, Kärre K, Carbone E, Cavallo F.

Oncoimmunology. 2017 Feb 23;6(3):e1284718. doi: 10.1080/2162402X.2017.1284718. eCollection 2017.

6.

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients.

Tallerico R, Cristiani CM, Staaf E, Garofalo C, Sottile R, Capone M, Pico de Coaña Y, Madonna G, Palella E, Wolodarski M, Carannante V, Mallardo D, Simeone E, Grimaldi AM, Johansson S, Frumento P, Gulletta E, Anichini A, Colucci F, Ciliberto G, Kiessling R, Kärre K, Ascierto PA, Carbone E.

Oncoimmunology. 2016 Dec 7;6(2):e1261242. doi: 10.1080/2162402X.2016.1261242. eCollection 2017.

7.

George Klein (1925-2016).

Ernberg I, Kärre K, Wigzell H.

Nature. 2017 Feb 15;542(7641):296. doi: 10.1038/542296a. No abstract available.

PMID:
28202974
8.

Independent control of natural killer cell responsiveness and homeostasis at steady-state by CD11c+ dendritic cells.

Luu TT, Ganesan S, Wagner AK, Sarhan D, Meinke S, Garbi N, Hämmerling G, Alici E, Kärre K, Chambers BJ, Höglund P, Kadri N.

Sci Rep. 2016 Dec 1;6:37996. doi: 10.1038/srep37996.

9.

Herpes simplex virus specific T cell response in a cohort with primary genital infection correlates inversely with frequency of subsequent recurrences.

Franzen-Röhl E, Schepis D, Atterfelt F, Franck K, Wikström A, Liljeqvist JÅ, Bergström T, Aurelius E, Kärre K, Berg L, Gaines H.

Sex Transm Infect. 2017 May;93(3):169-174. doi: 10.1136/sextrans-2016-052811. Epub 2016 Nov 30.

PMID:
27903680
10.

IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.

Kritikou JS, Dahlberg CI, Baptista MA, Wagner AK, Banerjee PP, Gwalani LA, Poli C, Panda SK, Kärre K, Kaech SM, Wermeling F, Andersson J, Orange JS, Brauner H, Westerberg LS.

Sci Rep. 2016 Aug 1;6:30636. doi: 10.1038/srep30636.

11.

In vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantation.

Lakshmikanth T, Heuts F, Muvva SS, Wallin RP, Persson AK, Fauriat C, Applequist SE, Ljunggren HG, Höglund P, Kärre K, Svensson M, Juarez JG.

Eur J Immunol. 2016 Jul;46(7):1758-69. doi: 10.1002/eji.201545991. Epub 2016 May 17.

12.

Microchip Screening Platform for Single Cell Assessment of NK Cell Cytotoxicity.

Guldevall K, Brandt L, Forslund E, Olofsson K, Frisk TW, Olofsson PE, Gustafsson K, Manneberg O, Vanherberghen B, Brismar H, Kärre K, Uhlin M, Önfelt B.

Front Immunol. 2016 Apr 5;7:119. doi: 10.3389/fimmu.2016.00119. eCollection 2016.

13.

Dynamic Regulation of NK Cell Responsiveness.

Kadri N, Wagner AK, Ganesan S, Kärre K, Wickström S, Johansson MH, Höglund P.

Curr Top Microbiol Immunol. 2016;395:95-114. doi: 10.1007/82_2015_485. Review.

PMID:
26658943
14.

Retuning of Mouse NK Cells after Interference with MHC Class I Sensing Adjusts Self-Tolerance but Preserves Anticancer Response.

Wagner AK, Wickström SL, Tallerico R, Salam S, Lakshmikanth T, Brauner H, Höglund P, Carbone E, Johansson MH, Kärre K.

Cancer Immunol Res. 2016 Feb;4(2):113-23. doi: 10.1158/2326-6066.CIR-15-0001. Epub 2015 Nov 20.

15.

HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.

Sottile R, Pangigadde PN, Tan T, Anichini A, Sabbatino F, Trecroci F, Favoino E, Orgiano L, Roberts J, Ferrone S, Kärre K, Colucci F, Carbone E.

Eur J Immunol. 2016 Feb;46(2):409-19. doi: 10.1002/eji.201445289. Epub 2015 Dec 20.

16.

Depletion of IL-2 receptor β-positive cells protects from diabetes in non-obese diabetic mice.

Brauner H, Hall HT, Flodström-Tullberg M, Kärre K, Höglund P, Johansson S.

Immunol Cell Biol. 2016 Feb;94(2):177-84. doi: 10.1038/icb.2015.78. Epub 2015 Aug 5.

PMID:
26244831
17.

Mechanical stress downregulates MHC class I expression on human cancer cell membrane.

La Rocca R, Tallerico R, Talib Hassan A, Das G, Lakshmikanth T, Matteucci M, Liberale C, Mesuraca M, Scumaci D, Gentile F, Cojoc G, Perozziello G, Ammendolia A, Gallo A, Kärre K, Cuda G, Candeloro P, Di Fabrizio E, Carbone E.

PLoS One. 2014 Dec 26;9(12):e111758. doi: 10.1371/journal.pone.0111758. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0118519. Tadepally, Lakshmikanth [corrected to Lakshmikanth, Tadepally].

18.

Classification of current anticancer immunotherapies.

Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G.

Oncotarget. 2014 Dec 30;5(24):12472-508. Review.

19.

Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients.

Ali TH, Pisanti S, Ciaglia E, Mortarini R, Anichini A, Garofalo C, Tallerico R, Santinami M, Gulletta E, Ietto C, Galgani M, Matarese G, Bifulco M, Ferrone S, Colucci F, Moretta A, Kärre K, Carbone E.

Nat Commun. 2014 Dec 4;5:5639. doi: 10.1038/ncomms6639.

20.

A genetic defect in mice that impairs missing self recognition despite evidence for normal maturation and MHC class I-dependent education of NK cells.

Wickström SL, Öberg L, Kärre K, Johansson MH.

J Immunol. 2014 Feb 15;192(4):1577-86. doi: 10.4049/jimmunol.1300960. Epub 2014 Jan 17.

21.

Natural killer cell inhibitory receptor expression in humans and mice: a closer look.

Sternberg-Simon M, Brodin P, Pickman Y, Onfelt B, Kärre K, Malmberg KJ, Höglund P, Mehr R.

Front Immunol. 2013 Mar 26;4:65. doi: 10.3389/fimmu.2013.00065. eCollection 2013.

22.

Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules.

Tallerico R, Todaro M, Di Franco S, Maccalli C, Garofalo C, Sottile R, Palmieri C, Tirinato L, Pangigadde PN, La Rocca R, Mandelboim O, Stassi G, Di Fabrizio E, Parmiani G, Moretta A, Dieli F, Kärre K, Carbone E.

J Immunol. 2013 Mar 1;190(5):2381-90. doi: 10.4049/jimmunol.1201542. Epub 2013 Jan 23.

23.

Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice.

Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, Chin KC, Kärre K, Pettersson S, Greicius G.

Carcinogenesis. 2012 Jun;33(6):1231-8. doi: 10.1093/carcin/bgs137. Epub 2012 Mar 29.

PMID:
22461519
24.

Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantation.

Gertow J, Berglund S, Okas M, Kärre K, Remberger M, Mattsson J, Uhlin M.

Clin Immunol. 2012 May;143(2):134-44. doi: 10.1016/j.clim.2012.01.018. Epub 2012 Feb 10.

PMID:
22386776
25.

Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets.

Brodin P, Lakshmikanth T, Kärre K, Höglund P.

J Immunol. 2012 Mar 1;188(5):2218-26. doi: 10.4049/jimmunol.1102801. Epub 2012 Jan 27.

26.

First International Meeting of the Thematic Centre for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC) 13-14 June 2011, Ljusterö, Sweden.

Choudhury A, Höglund P, Kiessling R, Kärre K, Lundqvist A, Malmberg K, Mellstedt H, Scheynius A, Winqvist O, Osterborg A.

Cancer Immunol Immunother. 2012 Apr;61(4):587-91. doi: 10.1007/s00262-011-1177-1. Epub 2012 Jan 15. No abstract available.

PMID:
22246566
27.

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.

Johansson SE, Rollman E, Chung AW, Center RJ, Hejdeman B, Stratov I, Hinkula J, Wahren B, Kärre K, Kent SJ, Berg L.

Viral Immunol. 2011 Oct;24(5):359-68. doi: 10.1089/vim.2011.0025. Epub 2011 Sep 29.

PMID:
21958370
28.

Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.

Li H, Lakshmikanth T, Garofalo C, Enge M, Spinnler C, Anichini A, Szekely L, Kärre K, Carbone E, Selivanova G.

Cell Cycle. 2011 Oct 1;10(19):3346-58. doi: 10.4161/cc.10.19.17630. Epub 2011 Oct 1.

PMID:
21941086
29.

Syntaxin 11 marks a distinct intracellular compartment recruited to the immunological synapse of NK cells to colocalize with cytotoxic granules.

Dabrazhynetskaya A, Ma J, Guerreiro-Cacais AO, Arany Z, Rudd E, Henter JI, Karre K, Levitskaya J, Levitsky V.

J Cell Mol Med. 2012 Jan;16(1):129-41. doi: 10.1111/j.1582-4934.2011.01280.x.

30.

Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis.

Franzen-Röhl E, Schepis D, Lagrelius M, Franck K, Jones P, Liljeqvist JÅ, Bergström T, Aurelius E, Kärre K, Berg L, Gaines H.

Clin Vaccine Immunol. 2011 Apr;18(4):655-60. doi: 10.1128/CVI.00333-10. Epub 2011 Feb 16.

31.

Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice.

Brodin P, Lakshmikanth T, Mehr R, Johansson MH, Duru AD, Achour A, Salmon-Divon M, Kärre K, Höglund P, Johansson S.

PLoS One. 2010 Oct 4;5(10). pii: e13174. doi: 10.1371/journal.pone.0013174.

32.

Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation.

Gertow J, Berglund S, Okas M, Uzunel M, Berg L, Kärre K, Mattsson J, Uhlin M.

Clin Exp Immunol. 2010 Oct;162(1):146-55. doi: 10.1111/j.1365-2249.2010.04212.x. Epub 2010 Aug 20.

33.

Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice.

Brauner H, Elemans M, Lemos S, Broberger C, Holmberg D, Flodström-Tullberg M, Kärre K, Höglund P.

J Immunol. 2010 Mar 1;184(5):2272-80. doi: 10.4049/jimmunol.0804358. Epub 2010 Feb 3.

34.

In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2.

Vahlne G, Lindholm K, Meier A, Wickström S, Lakshmikanth T, Brennan F, Wilken M, Nielsen R, Romagné F, Wagtmann NR, Kärre K, Johansson MH.

Eur J Immunol. 2010 Mar;40(3):813-23. doi: 10.1002/eji.200939755.

35.

Clinical expansion of cord blood-derived T cells for use as donor lymphocyte infusion after cord blood transplantation.

Okas M, Gertow J, Uzunel M, Karlsson H, Westgren M, Kärre K, Ringden O, Mattsson J, Uhlin M.

J Immunother. 2010 Jan;33(1):96-105. doi: 10.1097/CJI.0b013e3181b291a4.

PMID:
19952951
36.

NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients.

Johansson SE, Hejdeman B, Hinkula J, Johansson MH, Romagné F, Wahren B, Wagtmann NR, Kärre K, Berg L.

Clin Immunol. 2010 Feb;134(2):158-68. doi: 10.1016/j.clim.2009.10.001. Epub 2009 Nov 1.

PMID:
19880352
37.

Classical major histocompatibility complex class I molecules in motoneurons: new actors at the neuromuscular junction.

Thams S, Brodin P, Plantman S, Saxelin R, Kärre K, Cullheim S.

J Neurosci. 2009 Oct 28;29(43):13503-15. doi: 10.1523/JNEUROSCI.0981-09.2009.

38.

Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice.

Johansson S, Salmon-Divon M, Johansson MH, Pickman Y, Brodin P, Kärre K, Mehr R, Höglund P.

PLoS One. 2009 Jun 25;4(6):e6046. doi: 10.1371/journal.pone.0006046.

39.

Herpes simplex virus infection downmodulates NKG2D ligand expression.

Schepis D, D'Amato M, Studahl M, Bergström T, Kärre K, Berg L.

Scand J Immunol. 2009 May;69(5):429-36. doi: 10.1111/j.1365-3083.2009.02241.x. Epub 2009 Feb 26.

40.

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V, Biassoni R, Höglund P, Kato M, Shibuya K, Schadendorf D, Anichini A, Ferrone S, Velardi A, Kärre K, Shibuya A, Carbone E, Colucci F.

J Clin Invest. 2009 May;119(5):1251-63. doi: 10.1172/JCI36022. Epub 2009 Apr 6.

41.

Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantation.

Uhlin M, Okas M, Karlsson H, Gertow J, Henningsohn L, Ringdén O, Kärre K, Levitsky V, Mattsson J.

Transplantation. 2009 Feb 27;87(4):467-72. doi: 10.1097/TP.0b013e3181949c16.

PMID:
19307781
42.

NK cell education: not an on-off switch but a tunable rheostat.

Brodin P, Kärre K, Höglund P.

Trends Immunol. 2009 Apr;30(4):143-9. doi: 10.1016/j.it.2009.01.006. Epub 2009 Mar 11.

PMID:
19282243
43.

The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells.

Brodin P, Lakshmikanth T, Johansson S, Kärre K, Höglund P.

Blood. 2009 Mar 12;113(11):2434-41. doi: 10.1182/blood-2008-05-156836. Epub 2008 Oct 30. Erratum in: Blood.2010 Feb 11;115(6):1313.

44.

Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.

Schepis D, Gunnarsson I, Eloranta ML, Lampa J, Jacobson SH, Kärre K, Berg L.

Immunology. 2009 Jan;126(1):140-6. doi: 10.1111/j.1365-2567.2008.02887.x. Epub 2008 Jun 18.

45.

Natural killer cell recognition of missing self.

Kärre K.

Nat Immunol. 2008 May;9(5):477-80. doi: 10.1038/ni0508-477. No abstract available.

PMID:
18425103
46.

Pillars article: Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989. 340: 443-448.

Townsend A, Ohlén C, Bastin J, Ljunggren HG, Foster L, Kärre K.

J Immunol. 2007 Oct 1;179(7):4301-6. No abstract available.

47.

The expression of human natural killer cell receptors in early life.

Sundström Y, Nilsson C, Lilja G, Kärre K, Troye-Blomberg M, Berg L.

Scand J Immunol. 2007 Aug-Sep;66(2-3):335-44.

48.

Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.

Titanji K, Sammicheli S, De Milito A, Mantegani P, Fortis C, Berg L, Kärre K, Travi G, Tassandin C, Lopalco L, Rethi B, Tambussi G, Chiodi F.

Immunology. 2008 Feb;123(2):164-70. Epub 2007 Jul 11.

49.

Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.

de Matos CT, Berg L, Michaëlsson J, Felländer-Tsai L, Kärre K, Söderström K.

Immunology. 2007 Oct;122(2):291-301. Epub 2007 May 22.

50.

Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection.

Wagner CS, Riise GC, Bergström T, Kärre K, Carbone E, Berg L.

J Immunol. 2007 Mar 15;178(6):3536-43.

Supplemental Content

Support Center